Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Share capital (Narrative) (Details)

v3.20.1
Share capital (Narrative) (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Mar. 11, 2019
CAD ($)
shares
$ / shares
Mar. 06, 2019
CAD ($)
$ / shares
shares
Feb. 15, 2018
CAD ($)
$ / shares
shares
Dec. 31, 2019
CAD ($)
shares
Dec. 31, 2018
CAD ($)
shares
Shares reserved to meet outstanding stock options, warrants and deferred share units | shares 2,069,142 1,890,539
Proceeds from options exercises $ 95 $ 391
Shares issued in public offering | shares 2,246,094
Shares issued price per share in public offering | $ / shares $ 6.40
Proceeds from public offering $ 14,375 29,456 14,375
Share issue costs 1,480 2,499 1,480
Share issue costs including cash costs 863 2,499 1,148
Professional fees and regulatory costs $ 285 $ 1,779 $ 1,987
Compensation warrants issued to agents | shares 134,766
Compensation warrants issued to agents, value $ 332
Warrants exercise price per share | $ / shares $ 6.53
Warrants term 24 months
Warrants expiration date February 15, 2020
Exercised options to purchase common stock | shares [1] 139,877 626,875
Underwriters [Member]
Additional proceeds from options exercises $ 2,751
Proceeds from options exercises 29,456
Share issue costs including cash costs $ 2,499
Exercised options to purchase common stock | shares 504,855
Exercise price of option | $ / shares $ 5.45
Shares issued in public offering [Member]
Shares issued in public offering | shares 4,900,000
Shares issued price per share in public offering | $ / shares $ 5.45
Proceeds from public offering $ 26,705
[1] Of the 139,877 (2018 - 626,875) options exercised, 98,408 (2018 - 443,748) elected the cashless exercise, under which 63,727 shares (2018 - 297,626) were issued. These options would have otherwise been exercisable for proceeds of $229 (2018 - $975) on the exercise date.